4 analysts have expressed a variety of opinions on Ikena Oncology (NASDAQ:IKNA) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 1 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 1 | 0 | 0 | 0 | 0 |
| 2M Ago | 1 | 1 | 0 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $10.25, a high estimate of $11.00, and a low estimate of $8.00. Observing a downward trend, the current average is 6.82% lower than the prior average price target of $11.00.
Diving into Analyst Ratings: An In-Depth Exploration
In examining...
Login or create a forever free account to read this news
Sign up/Log in